HomeCompareADXS vs PLD

ADXS vs PLD: Dividend Comparison 2026

ADXS yields 331.37% · PLD yields 3.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ADXS wins by $2981.39M in total portfolio value
10 years
ADXS
ADXS
● Live price
331.37%
Share price
$0.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2987.30M
Annual income
$1,874,518,858.21
Full ADXS calculator →
PLD
PLD
● Live price
3.10%
Share price
$132.18
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$5.91M
Annual income
$4,750,725.19
Full PLD calculator →

Portfolio growth — ADXS vs PLD

📍 ADXS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodADXSPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ADXS + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ADXS pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADXS
Annual income on $10K today (after 15% tax)
$28,166.68/yr
After 10yr DRIP, annual income (after tax)
$1,593,341,029.48/yr
PLD
Annual income on $10K today (after 15% tax)
$263.66/yr
After 10yr DRIP, annual income (after tax)
$4,038,116.41/yr
At 15% tax rate, ADXS beats the other by $1,589,302,913.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADXS + PLD for your $10,000?

ADXS: 50%PLD: 50%
100% PLD50/50100% ADXS
Portfolio after 10yr
$1496.61M
Annual income
$939,634,791.70/yr
Blended yield
62.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

ADXS
Analyst Ratings
6
Buy
2
Hold
Consensus: Buy
Altman Z
-24.8
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+2.9% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADXS buys
0
PLD buys
0
No recent congressional trades found for ADXS or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricADXSPLD
Forward yield331.37%3.10%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$2987.30M$5.91M
Annual income after 10y$1,874,518,858.21$4,750,725.19
Total dividends collected$2879.16M$5.78M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusBuyBuy

Year-by-year: ADXS vs PLD ($10,000, DRIP)

YearADXS PortfolioADXS Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$43,837$33,137.27$11,241$540.96+$32.6KADXS
2$182,667$135,761.45$13,019$991.13+$169.6KADXS
3$724,155$528,700.93$15,801$1,870.97+$708.4KADXS
4$2,733,677$1,958,830.81$20,609$3,701.21+$2.71MADXS
5$9,835,841$6,910,807.10$29,919$7,867.97+$9.81MADXS
6$33,762,918$23,238,567.70$50,631$18,617.74+$33.71MADXS
7$110,677,420$74,551,098.17$105,528$51,352.20+$110.57MADXS
8$346,821,277$228,396,437.05$287,364$174,449.42+$346.53MADXS
9$1,039,984,991$668,886,225.19$1,081,760$774,280.77+$1038.90MADXS
10$2,987,302,799$1,874,518,858.21$5,908,209$4,750,725.19+$2981.39MADXS

ADXS vs PLD: Complete Analysis 2026

ADXSStock

Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company's lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.

Full ADXS Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this ADXS vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADXS vs SCHDADXS vs JEPIADXS vs OADXS vs KOADXS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.